Bellicum Pharmaceuticals Probability of Future Pink Sheet Price Finishing Under 0.61
| BLCMDelisted Stock | USD 0.37 0.05 11.90% |
Bellicum |
Bellicum Pharmaceuticals Target Price Odds to finish below 0.61
The tendency of Bellicum Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under $ 0.61 after 90 days |
| 0.37 | 90 days | 0.61 | about 66.09 |
Based on a normal probability distribution, the odds of Bellicum Pharmaceuticals to stay under $ 0.61 after 90 days from now is about 66.09 (This Bellicum Pharmaceuticals probability density function shows the probability of Bellicum Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Bellicum Pharmaceuticals price to stay between its current price of $ 0.37 and $ 0.61 at the end of the 90-day period is about 38.17 .
Given the investment horizon of 90 days Bellicum Pharmaceuticals has a beta of 0.44 suggesting as returns on the market go up, Bellicum Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Bellicum Pharmaceuticals will be expected to be much smaller as well. Moreover Bellicum Pharmaceuticals has an alpha of 1.0612, implying that it can generate a 1.06 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Bellicum Pharmaceuticals Price Density |
| Price |
Predictive Modules for Bellicum Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bellicum Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bellicum Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bellicum Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Bellicum Pharmaceuticals is not an exception. The market had few large corrections towards the Bellicum Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bellicum Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bellicum Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.06 | |
β | Beta against Dow Jones | 0.44 | |
σ | Overall volatility | 0.24 | |
Ir | Information ratio | 0.04 |
Bellicum Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bellicum Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bellicum Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Bellicum Pharmaceuticals is not yet fully synchronised with the market data | |
| Bellicum Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Bellicum Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 1.5 M. Net Loss for the year was (24.97 M) with loss before overhead, payroll, taxes, and interest of (17.38 M). | |
| Bellicum Pharmaceuticals currently holds about 33.17 M in cash with (25.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.85, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Bellicum Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Bellicum Pink Sheet often depends not only on the future outlook of the current and potential Bellicum Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bellicum Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 30.8 M | |
| Cash And Short Term Investments | 21.8 M |
Bellicum Pharmaceuticals Technical Analysis
Bellicum Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Bellicum Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Bellicum Pharmaceuticals. In general, you should focus on analyzing Bellicum Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Bellicum Pharmaceuticals Predictive Forecast Models
Bellicum Pharmaceuticals' time-series forecasting models is one of many Bellicum Pharmaceuticals' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Bellicum Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Bellicum Pharmaceuticals
Checking the ongoing alerts about Bellicum Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Bellicum Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Bellicum Pharmaceuticals is not yet fully synchronised with the market data | |
| Bellicum Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Bellicum Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 1.5 M. Net Loss for the year was (24.97 M) with loss before overhead, payroll, taxes, and interest of (17.38 M). | |
| Bellicum Pharmaceuticals currently holds about 33.17 M in cash with (25.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.85, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Bellicum Pink Sheet
If you are still planning to invest in Bellicum Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bellicum Pharmaceuticals' history and understand the potential risks before investing.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |